| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 750,954 | 747,170 | 737,463 | | Cost of Revenue | 637,261 | 626,771 | 624,518 | | | Gross Profit | 113,693 | 120,399 | 112,945 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 113,010 | 112,473 | 93,511 | | Non Recurring | 7,443 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (6,760) | 7,926 | 19,434 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 100 | 241 | 580 | | Earnings Before Interest And Taxes | (6,660) | 8,167 | 20,014 | | Interest Expense | 3,141 | 4,570 | 3,850 | | Income Before Tax | (9,801) | 3,597 | 16,164 | | Income Tax Expense | (837) | 766 | 7,991 | | Minority Interest | (271) | (312) | (456) | | | | Net Income From Continuing Ops | (9,235) | 2,519 | 7,717 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (9,235) | 2,519 | 7,717 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,235) | $2,519 | $7,717 |
|
0.35% Nasdaq 
Income Statement
